Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component
of a variety of disease processes, including chronic thromboembolic disease, connective …

Essentials• The clinical value of IgM antibodies in thrombotic antiphospholipid syndrome
(APS) is debated.• By review of literature, we reconsidered the clinical value of IgM …

Background—Heart valve disease (HVD) is frequent in patients with systemic lupus
erythematosus (SLE), and the role of antiphospholipid antibodies (aPL) is controversial …

Cardiovascular diseases are one of the most important causes of the disability and mortality
in patients with systemic lupus erythematosus (SLE). The present study examined the …

Autoimmune diseases (AD) represent a broad spectrum of chronic conditions that may afflict
specific target organs or multiple systems with a significant burden on quality of life. These …

Background According to criteria for the classification of Systemic Lupus Erythematosus
(SLE), thrombocytopenia is one of the disease-defining hematologic disorders. Since the …

Background Pulmonary hypertension (PH) is a life-threatening condition that may affect
outcomes in patients with systemic lupus erythematosus (SLE). The role of antiphospholipid …

Background—Systemic lupus erythematosus (SLE) is associated with premature
atherosclerosis and vascular stiffening. Whether SLE alters left ventricular (LV) structure and …

Objective. This study was performed to determine the prevalence of and associated risk
factors for cardiovascular disease (CVD) in Latin American (LA) patients with systemic lupus …

Objectives We aimed to study the frequency, severity and predictors of valvular heart
disease (VHD) in our lupus cohort. Material and Methods 211 patients were included. A …